Structural dynamics of LDL receptor interactions with E498A and R499G variants of PCSK9

Related articles

1. The COPI coatomer regulates several steps of HDL metabolism

   This article has 31 authors:

   1. Grigorios Panteloglou
   2. Paolo Zanoni
   3. Christopher S. Law
   4. Brian Woods
   5. Alaa Othman
   6. Mustafa Yalcinkaya
   7. Simon F. Norrelykke
   8. Andrzej J. Rzepiela
   9. Szymon Stoma
   10. Michael Stebler
   11. Anja Kerksiek
   12. Michele Visentin
   13. Marieke Smit
   14. Sofia Kakava
   15. Anton Potapenko
   16. Eveline Schlumpf
   17. Silvija Radosavljevic
   18. Marta Futema
   19. Nawar Dalila
   20. Anne Tybjaerg-Hansen
   21. Steve E. Humphries
   22. Jan Albert Kuivenhoven
   23. Bart van de Sluis
   24. Dieter Lütjohann
   25. Roger Meier
   26. Jérôme Robert
   27. Janet Chou
   28. Raif S. Geha
   29. Anthony K. Shum
   30. Lucia Rohrer
   31. Arnold von Eckardstein

2. Translating the effect of dual lipid reduction with PCSK9 inhibitors on mechanical vascular instrumental biomarker in familial hypercholesterolemia subjects.

   This article has 14 authors:

   1. Giosiana Bosco
   2. Francesco Di Giacomo Barbagallo
   3. Maurizio Di Marco
   4. Sabrina Scilletta
   5. Nicoletta Miano
   6. Claudia Pistritto
   7. Mariapaola Tiralongo
   8. Cecilia Di Stefano
   9. Giovanni Pennisi
   10. Ernestina Marianna De Francesco
   11. Roberta Malaguarnera
   12. Antonino Di Pino
   13. Salvatore Piro
   14. Roberto Scicali

3. The Functional Interaction Between PRDM16 and the SREBP Pathway Controls Lipid Metabolism

   This article has 5 authors:

   1. Hafiz Majid Mahmood
   2. Maria Teresa Bengoechea-Alonso
   3. Dana E. Al-Ansari
   4. Khaled Machaca
   5. Johan Ericsson